Pharmaceutical Industry in
Lausanne
41 companies in Pharmaceutical Industry based in Lausanne — name and year of registration from the commercial register. The list below shows them all.
All 41 companies in Lausanne
Medifit MTC Sàrl
Since 2007 · 21–50 empl.4.8(61)
Medifit MTC Sàrl is a physiotherapy centre offering rehabilitation, physiotherapy treatments and medical training therapy (MTT). Services include in-clinic and home-based physiotherapy, manual therapy using the SOLÈRE® method and specialised care for areas such as orthopaedics, neurology and oncology.
Medifit effusion service Sàrl
Since 2021 · 1–10 empl.4.8(61)
Medifit effusion service Sàrl provides physiotherapy and rehabilitation services, including general and sports physiotherapy, manual therapy (Méthode SOLÈRE®) and medical training therapy (MTT). The practice also offers home physiotherapy, lymphatic drainage, oncology and geriatric rehabilitation, and therapeutic modalities such as cryotherapy, electrostimulation and shockwave therapy.
Medifit physiothérapie à domicile Sàrl
Since 2021 · 1–10 empl.4.8(61)
Medifit physiothérapie à domicile Sàrl is a provider of physiotherapy services offering rehabilitation, medical training therapy (MTT) and home-based physiotherapy. The organisation operates clinics in Lausanne, Morges and Yverdon-les-Bains and provides home care services in Vevey.
Medifit physiothérapie et sport Sàrl
Since 2021 · 1–10 empl.4.8(61)
Medifit physiothérapie et sport Sàrl is a physiotherapy centre offering rehabilitation, sports physiotherapy and home-care physiotherapy. Services include orthopaedic, trauma and neurological treatments, medical training therapy (MTT), manual therapy using the SOLÈRE® method and equipment-supported therapies such as shockwave, electrostimulation and isokinetic assessment.
Medifit Service Sàrl
Since 2021 · 1–10 empl.4.8(61)
Medifit Service Sàrl provides physiotherapy, rehabilitation and medical training services, including home physiotherapy. Offerings include sports physiotherapy, manual therapy (Méthode SOLÈRE®), Medical Training Therapy (MTT) and device-based treatments such as cryocompression, electrostimulation and shockwave therapy.
Medifit Groupe SA
Since 2023 · 1–10 empl.4.8(61)
Medifit Groupe SA provides physiotherapy services including rehabilitation, sports physiotherapy and home-based physiotherapy. Its services cover orthopaedic, neurological and geriatric rehabilitation, manual therapy (Méthode SOLÈRE®), medical training therapy (MTT) and adjunct treatments such as cryotherapy, shockwave therapy and electrostimulation.
AC Immune SA
Since 2003 · 101–500 empl.5.0(2)
The core activity of AC Immune SA is the development of therapeutics for neurodegenerative diseases, particularly Alzheimer's disease, and other central nervous system disorders. The company focuses on researching, developing and commercializing innovative medicines and therapies in collaboration with leading pharmaceutical and biotechnology companies, academic institutions and patient organizations.
FONDATION EUROVACC
Since 2002 · 11–20 empl.
The core activity of EuroVacc is the development of safe and effective vaccines against HIV and other infectious diseases through the promotion and support of international collaborations with leading vaccine researchers and developers in the public and private sectors.
AMAZENTIS SA
Since 2007 · 51–100 empl.
AMAZENTIS SA develops clinically studied nutritional ingredients and consumer health products targeting cellular and mitochondrial health and age-related declines in muscle function. The company markets its proprietary ingredient Mitopure through the Timeline® consumer brand and lists Nestlé Health Science as a global strategic partner.
Excellness Biotech SA
Since 2009 · 1–10 empl.
Excellness Biotech SA develops biomimetic cell culture substrates with defined elasticity for laboratory use. The company offers soft culture surfaces and wrinkling substrates used to study cell behavior and contraction.
Laboratoire Pharmessence, Luc-Henri Geny
Since 2013 · 1–10 empl.
Pharmessence is a laboratory specializing in the manufacture and distribution of plant-based medicines and products for phytotherapy and aromatherapy. The company's core activity encompasses the development and production of: plant-based preparations (e.g. essential oils, hydrolats, vegetable oils, lipid extracts); magistral preparations for pharmacies; and medicinal products based on plant extracts. The company primarily offers its products to professional customers, such as pharmacies and medical professionals.
fondation Innovative Medicines for Tuberculosis (iM4TB)
Since 2014 · 11–20 empl.
The core activity of iM4TB is the development of innovative medicines to combat tuberculosis. The company researches and develops new treatment methods and agents to eliminate tuberculosis.
Axalbion SA
Since 2017 · 11–20 empl.
Axalbion SA is a clinical-stage biopharmaceutical company developing TRPM8 agonists. Its lead candidate AX-8 is being developed for topical treatment of refractory chronic cough and dry eye syndrome.
Tigen Pharma SA
Since 2017 · 11–20 empl.
The core activity of Tigen Pharma is the development and acceleration of access to new therapies in the field of cell and gene therapy, particularly for the treatment of cancer. The company combines scientific expertise, technological capabilities and a long-term perspective to develop innovative solutions for patients and society.
Orgenesis Switzerland Sàrl
Since 2020 · 11–20 empl.
Orgenesis Switzerland Sàrl develops and implements the POCare platform for cell and gene therapies, focusing on process development, validation and automated closed‑loop bioprocessing units (OMPUL™) for decentralized point‑of‑care production.
Oculis Operations Sàrl
Since 2022 · 21–50 empl.
The core activity of Oculis is the development and research of innovative treatments and medications for eye diseases, particularly in the areas of Diabetic Maculopathy, dry eye, Uveitis and acute Optic Neuritis. The company focuses on developing highly effective and patient-centered solutions to improve the treatment of eye diseases and preserve patients' vision.
ABRA Sàrl
Since 2010 · 1–10 empl.
The core activity of Abra-Pharma is to advise and support pharmaceutical, bio-pharmaceutical and biotechnology companies in the market authorization and launch of their medicines in Switzerland and the EU. This includes services such as regulatory approval consulting, market access, sales and distribution of medicines. Additionally, the company researches natural solutions for various diseases and offers innovative medical products, such as wound healing solutions and blood volume analyzers.
Avrion Therapeutics SA
Since 2020 · 11–20 empl.
The core activity of Avrion Tx is the development of gene therapies, particularly for the treatment of rare diseases and specific forms of blindness.
ReproNovo SA
Since 2021 · 11–20 empl.
The core activity of ReproNovo is the development of innovative solutions for reproductive medicine and women's health, particularly the treatment of infertility and adenomyosis. The company focuses on developing therapeutic approaches to improve the success rates of assisted reproductive technologies and to develop new treatment options for men with hypogonadism and women with adenomyosis.
Aspeya Switzerland SA
Since 2024 · 21–50 empl.
Aspeya Switzerland SA develops and commercializes wellness and healthcare products and brands, focusing on consumer health, cannabinoid applications (via its Verdeya subsidiary), and inhaled therapeutics. The company applies scientific research and product development and leverages the oral-technology platform of Fertin Pharma, a contract development and manufacturing organization owned by Aspeya, to develop scalable formulations and delivery systems.
AB2 Bio SA
Since 2010 · 11–20 empl.5.0(2)
Neurocol Operations Sàrl
Since 2025 · 1–10 empl.
Neurocol Operations Sàrl develops and advances biopharmaceutical programs for neuro-ophthalmic and ophthalmic conditions with significant unmet medical needs. Its work focuses on the clinical candidates Privosegtor and Licaminlimab and on the development of related therapies.
Grand Medical Group AG
Since 2012 · 1–10 empl.2.0(1)
The core activity of Grand Medical Group AG is the development, production, registration and introduction of modern, innovative pharmaceutical products based on organic, synthetic and plant-based compounds. The company is active in all stages of the pharmaceutical business, including research and development, production, registration, distribution and marketing of medicines and health supplements.
Laboratoire O2&VIE SA
Since 2025 · 1–10 empl.
Laboratoire O2&VIE SA develops and sells nutritional supplements based on scientific research for healthcare professionals and their patients. Its activities focus on functional nutrition, with formulas built from natural active ingredients for different metabolic and health areas.
Baio Labs Sàrl
Since 2025 · 1–10 empl.
Biodelphis Therapeutics SA
Since 2026 · 1–10 empl.
Biodelphis Therapeutics SA is a Swiss biotechnology company and EPFL spin-off developing Antibody-Peptide Inhibitor Conjugates (APIC) and other protease inhibitor therapies. Its work focuses on a preclinical pipeline for applications in oncology, osteoporosis and autoimmune diseases.
SwissNovaGene Sàrl
Since 2026 · 1–10 empl.
SwissNovaGene Sàrl is a Swiss biotechnology company that develops active micronutrition formulas and validates them in human clinical studies. Under the Move brand, it offers food supplements for areas such as sleep, immunity, stress, metabolism, and recovery.
CHRONDEL SA
Since 2015 · 1–10 empl.
OrBioteK Sàrl
Since 2016 · 1–10 empl.
ECS-Progastrin SA
Since 2016 · 1–10 empl.
COMBISIN Sàrl
Since 2017 · 1–10 empl.
TATWA Sàrl
Since 2018 · 1–10 empl.
Sénèque SA
Since 2018 · 1–10 empl.
Imalia SA
Since 2022 · 1–10 empl.
OSASUNA Therapeutics SA
Since 2022 · 1–10 empl.
Beech Biotech SA
Since 2022 · 1–10 empl.
Leman Biotech Lausanne SA
Since 2022 · 1–10 empl.
SwitchKine SA
Since 2023 · 1–10 empl.
EpiCure Biotechnologies SA
Since 2024 · 1–10 empl.
HepaVue Dx Sàrl
Since 2024 · 1–10 empl.
Juvion Health Sciences SA
Since 2024 · 1–10 empl.
Pharmaceutical Industry in Lausanne
Pharmaceutical Industry in other places
By canton